The discrepancies among the above findings on the role of DR3 in innate colitis may be due to differential experimental settings using genetic-deficient mice compared with transient blockade of DR3 signaling using TL1A neutralization antibody or DR3-Fc. This evidence concerns the gene TNFRSF25 and colitis.